Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-Importance of slow dissociation and relaxation rates for antiviral efficacy
- PMID: 20599774
- DOI: 10.1016/j.bcp.2010.06.035
Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-Importance of slow dissociation and relaxation rates for antiviral efficacy
Abstract
The importance of slow dissociation of non-nucleoside reverse transcriptase inhibitors (NNRTIs) for antiviral effect has been investigated. The kinetic characteristics of a series of NNRTIs interacting with wild type and drug resistant variants of HIV-1 RT (EC 2.7.7.49) were analyzed by SPR biosensor technology. The antiviral effect was determined in MT-4 and peripheral blood mononuclear cells. Due to extremely slow dissociation rates and a complex interaction mechanism, rate constants could not be quantified. Instead, interaction characteristics were qualitatively analyzed using simulated sensorgrams. The simplest model describing these interactions adequately was an induced fit mechanism, i.e. a mechanism involving the formation of an initial enzyme-inhibitor complex subsequently transformed into a more stable complex. Differences in rates of dissociation from the initial complex and rates of relaxation from the induced complex explained (1) the differences in the amounts of formed complex, (2) the stability of the complex and (3) the antiviral efficacies of the compounds. The effect of NNRTI binding site mutations also correlated with these kinetic characteristics. MIV-170 was the most effective inhibitor of wild type and mutant HIV-1 in cell culture, a property that was associated with the formation of the largest amount of complex and the slowest relaxation and dissociation rates. This study supports the hypothesis that the efficacy of anti-HIV drugs is dependent on slow dissociation from the target, thereby maximizing the duration of the inhibitory effect. It also illustrates the strength of simulating interaction data for qualitative analysis of tight-binding drugs and the importance of resolving the kinetic mechanism of drug-target interactions.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation.Antiviral Res. 2010 Jun;86(3):268-75. doi: 10.1016/j.antiviral.2010.03.008. Epub 2010 Mar 20. Antiviral Res. 2010. PMID: 20307579
-
New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.J Med Chem. 1998 Jun 4;41(12):2076-89. doi: 10.1021/jm9800595. J Med Chem. 1998. PMID: 9622549
-
Screening for NNRTIs with slow dissociation and high affinity for a panel of HIV-1 RT variants.J Biomol Screen. 2009 Apr;14(4):395-403. doi: 10.1177/1087057109333977. J Biomol Screen. 2009. PMID: 19403922
-
The effect of NNRTIs on HIV reverse transcriptase dimerization.Curr Opin Investig Drugs. 2003 Aug;4(8):966-73. Curr Opin Investig Drugs. 2003. PMID: 14508881 Review.
-
Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors.Int J Biochem Cell Biol. 2004 Sep;36(9):1735-51. doi: 10.1016/j.biocel.2004.02.026. Int J Biochem Cell Biol. 2004. PMID: 15183341 Review.
Cited by
-
Non-nucleoside Reverse Transcriptase Inhibitors Inhibit Reverse Transcriptase through a Mutually Exclusive Interaction with Divalent Cation-dNTP Complexes.Biochemistry. 2019 Apr 23;58(16):2176-2187. doi: 10.1021/acs.biochem.9b00028. Epub 2019 Apr 5. Biochemistry. 2019. PMID: 30900874 Free PMC article.
-
Biophysics in drug discovery: impact, challenges and opportunities.Nat Rev Drug Discov. 2016 Oct;15(10):679-98. doi: 10.1038/nrd.2016.123. Epub 2016 Aug 12. Nat Rev Drug Discov. 2016. PMID: 27516170 Review.
-
Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.Biomolecules. 2013 Nov 1;3(4):889-904. doi: 10.3390/biom3040889. Biomolecules. 2013. PMID: 24970195 Free PMC article.
-
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.Antimicrob Agents Chemother. 2011 Apr;55(4):1403-13. doi: 10.1128/AAC.01426-10. Epub 2011 Jan 31. Antimicrob Agents Chemother. 2011. PMID: 21282453 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical